FDA scientists opposed Trump's plan to ease peptides access

Summarised from 2 outlets · Updated 28 Oct, 16:14 · Archive

FDA scientists opposed the Trump administration's effort to loosen rules on unproven peptide drugs.

The Trump administration has proposed a plan to give Americans easier access to unproven peptide drugs favoured by Health Secretary Robert F. Kennedy Jr. Most FDA scientific staff members opposed the effort, according to six people familiar with the policy's development. The FDA scientists had limited input in drafting the policy and warned it could undermine the agency's longstanding mission of keeping unproven health products off the market.

The policy would direct the FDA not to take action against specialty pharmacies that sell certain widely used peptides. These substances would otherwise be considered illegal drugs because they have not gone through the agency's rigorous review process for safety and effectiveness. The document covers injectable peptides popular within the wellness industry and recently underwent regulatory review at the White House, typically the final step before publication.

The peptides subject to the new policy include BPC-157 and TB-500, which are promoted to help heal injuries and build muscle. Both are considered doping substances by international sports authorities. Kennedy has described himself as a 'big fan' of peptides and recently said he used BPC-157 to treat a muscle injury. An HHS spokesperson did not immediately respond to requests for comment.

How it is being reported

• FDA scientists opposed the Trump administration's effort to ease peptides accessFood and Drug Administration scientists did not support an effort by President Donald Trump's administration to loosen rules on unproven peptide drugs.News4Jax · 28 Oct, 15:51
• FDA scientists opposed the Trump administration's effort to ease peptides accessFood and Drug Administration scientists did not support an effort by President Donald Trump's administration to loosen rules on unproven peptide drugs.Clickorlando · 28 Oct, 15:51

In this story: Trump · Robert F. Kennedy Jr. · Food and Drug Administration · Department of Health and Human Services · United States

This summary was written by AI from the headlines and standfirsts above, and states as fact only what at least two outlets report. How we use AI · Report a problem · Corrections log